Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum

Jaimie P. Meyer, Yavar Moghimi, Ruthanne Marcus, Joseph K. Lim, Alain H. Litwin, Frederick L. Altice

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Background: With the explosion of newly available direct acting antiviral (DAA) Hepatitis C virus (HCV) treatments that demonstrate 95% sustained virologic response (SVR) rates, evidence-based strategies are urgently needed to achieve real-world effectiveness in challenging patient populations. While HIV is incurable, lessons from over 30 years of experience overcoming obstacles to the HIV treatment cascade could be applied to the HCV context. Methods: Using Institute of Medicine guidelines, we conducted a systematic review of published interventions from PubMed, Medline, GoogleScholar, EmBASE, and PsychInfo bibliographic databases and citation indices. Abstracts were first screened by three independent reviewers and studies were included if they involved original research, described a specific intervention, were published in English in a peer-reviewed journal between 2001 and 2014, and had full text available. Results: Evidence-based interventions to enhance HCV assessment, treatment, and adherence generally fell into one of 4 categories, including those involving: (1) diagnosis or case-finding; (2) linkage to HCV care; (3) pre-therapeutic evaluation or treatment initiation; or (4) treatment adherence. While most available eligible studies described interventions using non-contemporary interferon-based HCV treatments, future research will need to address how these interventions apply to the context of well-tolerated, simple, oral treatment regimens. In some cases, we explored how HIV-specific interventions might be modified to fit the HCV spectrum of care engagement. Conclusions: Evidence-based interventions should be strategically incorporated into HCV treatment implementation efforts to most effectively deliver treatment and maximize treatment outcomes.

Original languageEnglish (US)
Pages (from-to)922-935
Number of pages14
JournalInternational Journal of Drug Policy
Volume26
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Continuity of Patient Care
Chronic Hepatitis C
Hepacivirus
Therapeutics
HIV
Bibliographic Databases
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Explosions
PubMed
Interferons
Antiviral Agents
Guidelines

Keywords

  • Care continuum
  • Hepatitis C
  • Implementation
  • Interventions

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Health Policy

Cite this

Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. / Meyer, Jaimie P.; Moghimi, Yavar; Marcus, Ruthanne; Lim, Joseph K.; Litwin, Alain H.; Altice, Frederick L.

In: International Journal of Drug Policy, Vol. 26, No. 10, 01.10.2015, p. 922-935.

Research output: Contribution to journalArticle

Meyer, Jaimie P. ; Moghimi, Yavar ; Marcus, Ruthanne ; Lim, Joseph K. ; Litwin, Alain H. ; Altice, Frederick L. / Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. In: International Journal of Drug Policy. 2015 ; Vol. 26, No. 10. pp. 922-935.
@article{1ad5f2c4a7fd4c1599d341473ace2daa,
title = "Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum",
abstract = "Background: With the explosion of newly available direct acting antiviral (DAA) Hepatitis C virus (HCV) treatments that demonstrate 95{\%} sustained virologic response (SVR) rates, evidence-based strategies are urgently needed to achieve real-world effectiveness in challenging patient populations. While HIV is incurable, lessons from over 30 years of experience overcoming obstacles to the HIV treatment cascade could be applied to the HCV context. Methods: Using Institute of Medicine guidelines, we conducted a systematic review of published interventions from PubMed, Medline, GoogleScholar, EmBASE, and PsychInfo bibliographic databases and citation indices. Abstracts were first screened by three independent reviewers and studies were included if they involved original research, described a specific intervention, were published in English in a peer-reviewed journal between 2001 and 2014, and had full text available. Results: Evidence-based interventions to enhance HCV assessment, treatment, and adherence generally fell into one of 4 categories, including those involving: (1) diagnosis or case-finding; (2) linkage to HCV care; (3) pre-therapeutic evaluation or treatment initiation; or (4) treatment adherence. While most available eligible studies described interventions using non-contemporary interferon-based HCV treatments, future research will need to address how these interventions apply to the context of well-tolerated, simple, oral treatment regimens. In some cases, we explored how HIV-specific interventions might be modified to fit the HCV spectrum of care engagement. Conclusions: Evidence-based interventions should be strategically incorporated into HCV treatment implementation efforts to most effectively deliver treatment and maximize treatment outcomes.",
keywords = "Care continuum, Hepatitis C, Implementation, Interventions",
author = "Meyer, {Jaimie P.} and Yavar Moghimi and Ruthanne Marcus and Lim, {Joseph K.} and Litwin, {Alain H.} and Altice, {Frederick L.}",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.drugpo.2015.05.002",
language = "English (US)",
volume = "26",
pages = "922--935",
journal = "International Journal of Drug Policy",
issn = "0955-3959",
publisher = "Elsevier",
number = "10",

}

TY - JOUR

T1 - Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum

AU - Meyer, Jaimie P.

AU - Moghimi, Yavar

AU - Marcus, Ruthanne

AU - Lim, Joseph K.

AU - Litwin, Alain H.

AU - Altice, Frederick L.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: With the explosion of newly available direct acting antiviral (DAA) Hepatitis C virus (HCV) treatments that demonstrate 95% sustained virologic response (SVR) rates, evidence-based strategies are urgently needed to achieve real-world effectiveness in challenging patient populations. While HIV is incurable, lessons from over 30 years of experience overcoming obstacles to the HIV treatment cascade could be applied to the HCV context. Methods: Using Institute of Medicine guidelines, we conducted a systematic review of published interventions from PubMed, Medline, GoogleScholar, EmBASE, and PsychInfo bibliographic databases and citation indices. Abstracts were first screened by three independent reviewers and studies were included if they involved original research, described a specific intervention, were published in English in a peer-reviewed journal between 2001 and 2014, and had full text available. Results: Evidence-based interventions to enhance HCV assessment, treatment, and adherence generally fell into one of 4 categories, including those involving: (1) diagnosis or case-finding; (2) linkage to HCV care; (3) pre-therapeutic evaluation or treatment initiation; or (4) treatment adherence. While most available eligible studies described interventions using non-contemporary interferon-based HCV treatments, future research will need to address how these interventions apply to the context of well-tolerated, simple, oral treatment regimens. In some cases, we explored how HIV-specific interventions might be modified to fit the HCV spectrum of care engagement. Conclusions: Evidence-based interventions should be strategically incorporated into HCV treatment implementation efforts to most effectively deliver treatment and maximize treatment outcomes.

AB - Background: With the explosion of newly available direct acting antiviral (DAA) Hepatitis C virus (HCV) treatments that demonstrate 95% sustained virologic response (SVR) rates, evidence-based strategies are urgently needed to achieve real-world effectiveness in challenging patient populations. While HIV is incurable, lessons from over 30 years of experience overcoming obstacles to the HIV treatment cascade could be applied to the HCV context. Methods: Using Institute of Medicine guidelines, we conducted a systematic review of published interventions from PubMed, Medline, GoogleScholar, EmBASE, and PsychInfo bibliographic databases and citation indices. Abstracts were first screened by three independent reviewers and studies were included if they involved original research, described a specific intervention, were published in English in a peer-reviewed journal between 2001 and 2014, and had full text available. Results: Evidence-based interventions to enhance HCV assessment, treatment, and adherence generally fell into one of 4 categories, including those involving: (1) diagnosis or case-finding; (2) linkage to HCV care; (3) pre-therapeutic evaluation or treatment initiation; or (4) treatment adherence. While most available eligible studies described interventions using non-contemporary interferon-based HCV treatments, future research will need to address how these interventions apply to the context of well-tolerated, simple, oral treatment regimens. In some cases, we explored how HIV-specific interventions might be modified to fit the HCV spectrum of care engagement. Conclusions: Evidence-based interventions should be strategically incorporated into HCV treatment implementation efforts to most effectively deliver treatment and maximize treatment outcomes.

KW - Care continuum

KW - Hepatitis C

KW - Implementation

KW - Interventions

UR - http://www.scopus.com/inward/record.url?scp=84941807523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941807523&partnerID=8YFLogxK

U2 - 10.1016/j.drugpo.2015.05.002

DO - 10.1016/j.drugpo.2015.05.002

M3 - Article

C2 - 26077144

AN - SCOPUS:84941807523

VL - 26

SP - 922

EP - 935

JO - International Journal of Drug Policy

JF - International Journal of Drug Policy

SN - 0955-3959

IS - 10

ER -